A NHMRC Leadership Fellow and a Mathew Flinders Professor at Flinders University and Director of the Adelaide Institute for Sleep Health, Dr. Danny Eckert leads a comprehensive basic sciences and translational research program that focuses on identification of the causes of sleep apnoea, optimisation of existing therapies, and development of new tailored therapies. Dr. Eckert is most well-known for his pioneering endo-phenotyping work which has led to a new precision medicine therapeutic framework to understand and treat OSA and for his role in the development of novel pharmacotherapy. He has ~200 publications in the leading sleep/respiratory medicine and other cross-disciplinary and general medical journals. Dr. Eckert’s previous appointments include Professor of Medicine, UNSW and Principal Research Scientist at NeuRA in Sydney where he maintains affiliate appointments. Prior to 2011, he was an Assistant Professor in Sleep Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston.